We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+5.94%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$204M
AUM Growth
+$28.8M
(+16%)
Cap. Flow
-$85M
Cap. Flow
% of AUM
-41.63%
Top 10 Holdings %
Top 10 Hldgs %
70.21%
Holding
119
New
19
Increased
29
Reduced
17
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organogenesis Holdings
ORGO
|
+$1.06M |
| 2 |
ALNA
Allena Pharmaceuticals
ALNA
|
+$802K |
| 3 |
Arlo Technologies
ARLO
|
+$800K |
| 4 |
CASA
Casa Systems, Inc. Common Stock
CASA
|
+$752K |
| 5 |
ON Semiconductor
ON
|
+$737K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$2.19M |
| 2 |
AVTR.PRA
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
|
+$1.6M |
| 3 |
Silicom
SILC
|
+$1.31M |
| 4 |
Smith Micro Software
SMSI
|
+$971K |
| 5 |
AVID
Avid Technology Inc
AVID
|
+$899K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.43% |
| 2 | Technology | 6.86% |
| 3 | Industrials | 1.87% |
| 4 | Consumer Discretionary | 0.44% |
| 5 | Financials | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teladoc Health
TDOC
$1.58B
| $3.25M | 1.59% |
38,800
+7,800
| +25% | +$594K |
|
2
CALL
Acadia Pharmaceuticals
ACAD
$4.25B
| $3.12M | 1.53% |
180,600
+168,600
| +1,405% | +$7.33M |
|
3
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.95M | 0.95% |
23,000
+200
| +0.9% | +$15.1K |
|
|
4
ON Semiconductor
ON
$33.8B
| $1.95M | 0.95% |
79,800
+34,900
| +78% | +$737K |
|
5
Nutanix
NTNX
$14.9B
| $1.74M | 0.85% |
55,650
+11,550
| +26% | +$341K |
|
|
FLNA
6
Filana Therapeutics
FLNA
$43M
| $1.49M | 0.73% |
232,442
-127,179
| -35% | -$220K |
|
7
Aspen Aerogels
ASPN
$387M
| $1.35M | 0.66% |
173,509
| – | – |
|
8
iShares Russell 2000 ETF
IWM
$80.9B
| $1.34M | 0.66% |
8,114
| – | – |
|
9
Airgain
AIRG
$74.3M
| $1.01M | 0.49% |
94,436
+34,248
| +57% | +$360K |
|
|
10
Arlo Technologies
ARLO
$1.4B
| $980K | 0.48% |
+232,761
| New | +$800K |
|
|
CFRX
11
DELISTED
ContraFect Corporation
CFRX
| $960K | 0.47% |
+1,933
| New | +$561K |
|
12
Knowles
KN
$3.22B
| $959K | 0.47% |
45,376
+5,514
| +14% | +$118K |
|
13
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
| $892K | 0.44% |
8,758
+2,257
| +35% | +$217K |
|
14
DNA X Inc
SONM
$4.69M
| $879K | 0.43% |
135
+58
| +75% | +$286K |
|
15
Clearfield
CLFD
$421M
| $875K | 0.43% |
62,760
+10,801
| +21% | +$140K |
|
|
DSPG
16
DELISTED
DSP Group Inc
DSPG
| $843K | 0.41% |
53,575
+7,600
| +17% | +$112K |
|
|
BDSI
17
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $841K | 0.41% |
133,050
-24,978
| -16% | -$147K |
|
18
Pixelworks
PXLW
$38.8M
| $840K | 0.41% |
17,866
-1,624
| -8% | -$66.5K |
|
|
19
Organogenesis Holdings
ORGO
$308M
| $808K | 0.4% |
+168,000
| New | +$1.06M |
|
|
ALIM
20
DELISTED
Alimera Sciences
ALIM
| $753K | 0.37% |
99,333
+71,389
| +255% | +$426K |
|
|
SCPH
21
DELISTED
scPharmaceuticals
SCPH
| $704K | 0.34% |
+124,505
| New | +$637K |
|
|
ALNA
22
DELISTED
Allena Pharmaceuticals
ALNA
| $667K | 0.33% |
+244,186
| New | +$802K |
|
23
Mirum Pharmaceuticals
MIRM
$6.89B
| $666K | 0.33% |
+27,148
| New | +$289K |
|
24
Digital Turbine
APPS
$1.02B
| $652K | 0.32% |
91,431
-15,404
| -14% | -$115K |
|
|
CASA
25
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $644K | 0.32% |
+157,500
| New | +$752K |
|
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Worth Venture Partners held 119 positions worth $204M, up 16% from $175M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Worth Venture Partners withdrew a net $85M in Q4 2019, closing 32 positions and reducing 17 holdings. Its most notable exit was Illumina, an estimated $2.19M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, up from 6.3% a quarter earlier, followed by Technology and Industrials.
Against the trend, Worth Venture Partners opened a new position in Organogenesis Holdings worth $808K.
- Worth Venture Partners's largest Q4 2019 buy was Organogenesis Holdings: 168,000 shares worth $808K.
- Worth Venture Partners added most to ON Semiconductor in Q4 2019, an estimated $737K increase.
- Worth Venture Partners's biggest Q4 2019 reduction was Seachange International Inc, cutting an estimated $829K.
- Worth Venture Partners fully exited Illumina in Q4 2019, selling an estimated $2.19M.
- Worth Venture Partners's ten largest holdings make up 70% of its $204M portfolio in Q4 2019.
- Worth Venture Partners opened 19 new positions and closed 32 in Q4 2019.
- Worth Venture Partners's portfolio value rose 16% quarter-over-quarter to $204M.
Based on Worth Venture Partners's 13F filing for Q4 2019, filed 14 Feb 2020.